OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALNS56

Alan Scott Enterprises Ltd

Medical Equipment, Supplies & DistributionVerified

Alan Scott Enterprises Ltd has a debt-to-equity ratio of 4.17, indicating a high reliance on debt financing relative to equity. The company's liquidity position is characterized by a current ratio of 1.45, suggesting it has sufficient short-term assets to cover its short-term liabilities, but the risk assessment flags a negative net cash position after subtracting total debt. The company's profitability is weak, with a negative return on equity of -1.026 and a return on assets of -0.0667. These metrics indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. Alan Scott Enterprises operates through several business verticals, including Alan Scott Retail, Alan Scott Robotics, Alan Scott Nano Technologies, and Alan Scott Web 3.0. The company's revenue is not disclosed by segment, but its operations span multiple industries, including healthcare, retail, and technology. The company's geographic exposure is primarily in India, with no significant international revenue disclosed. The company's growth trajectory is uncertain, as it reported a net loss of INR 18,164,200 and an operating loss of INR 18,683,210 in the latest financial period. The company's free cash flow is positive at INR 11,972,910, but this is offset by a negative operating cash flow of INR 16,838,920. The company's capital expenditure of INR 7,900,300 indicates ongoing investment in its operations. The company faces several risk factors, including a high debt-to-equity ratio and a negative net cash position. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's financial structure suggests a potential for dilution, but the risk is currently low. Recent events and filings do not provide specific details on the company's operations or financial performance. The company's latest financial snapshot indicates a challenging operating environment, with negative net income and operating income. The company's capital structure and liquidity position suggest a need for careful monitoring of its financial health.

30-day price · ALNS+17.00 (+7.6%)
Low$213.40High$301.40Close$241.00As of17 May, 00:00 UTC
Profile
CompanyAlan Scott Enterprises Ltd
TickerALNS.BO
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Alan Scott Enterprises Ltd is an India-based company focused on manufacturing health and hygiene equipment for hospitals and homes, with business verticals in retail, robotics, nano technologies, and Web 3.0.

Classification. The company is classified under the Healthcare economic sector, specifically in the Medical Equipment, Supplies & Distribution industry, with a confidence level of 0.92.

Alan Scott Enterprises Ltd has a debt-to-equity ratio of 4.17, indicating a high reliance on debt financing relative to equity. The company's liquidity position is characterized by a current ratio of 1.45, suggesting it has sufficient short-term assets to cover its short-term liabilities, but the risk assessment flags a negative net cash position after subtracting total debt. The company's profitability is weak, with a negative return on equity of -1.026 and a return on assets of -0.0667. These metrics indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. Alan Scott Enterprises operates through several business verticals, including Alan Scott Retail, Alan Scott Robotics, Alan Scott Nano Technologies, and Alan Scott Web 3.0. The company's revenue is not disclosed by segment, but its operations span multiple industries, including healthcare, retail, and technology. The company's geographic exposure is primarily in India, with no significant international revenue disclosed. The company's growth trajectory is uncertain, as it reported a net loss of INR 18,164,200 and an operating loss of INR 18,683,210 in the latest financial period. The company's free cash flow is positive at INR 11,972,910, but this is offset by a negative operating cash flow of INR 16,838,920. The company's capital expenditure of INR 7,900,300 indicates ongoing investment in its operations. The company faces several risk factors, including a high debt-to-equity ratio and a negative net cash position. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's financial structure suggests a potential for dilution, but the risk is currently low. Recent events and filings do not provide specific details on the company's operations or financial performance. The company's latest financial snapshot indicates a challenging operating environment, with negative net income and operating income. The company's capital structure and liquidity position suggest a need for careful monitoring of its financial health.
Key takeaways
  • Alan Scott Enterprises Ltd has a high debt-to-equity ratio of 4.17, indicating a significant reliance on debt financing.
  • The company's profitability is weak, with a negative return on equity of -1.026 and a return on assets of -0.0667.
  • The company operates through multiple business verticals, including healthcare, retail, and technology, with a primary focus in India.
  • The company's growth trajectory is uncertain, with a net loss and operating loss in the latest financial period.
  • The company faces medium liquidity risk and low dilution risk, with a negative net cash position after subtracting total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$286.9M
Gross profit$114.3M
Operating income-$18.7M
Net income-$18.2M
R&D
SG&A
D&A
SBC
Operating cash flow-$16.8M
CapEx-$7.9M
Free cash flow$12.0M
Total assets$272.5M
Total liabilities$254.8M
Total equity$17.7M
Cash & equivalents$7.7M
Long-term debt$73.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$17.7M
Net cash-$66.1M
Current ratio1.4
Debt/Equity4.2
ROA-6.7%
ROE-1.0%
Cash conversion93.0%
CapEx/Revenue-2.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
MetricALNSActivity
Op margin-6.5%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-6.3%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin39.9%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-2.8%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity417.0%69.3% medp25 63.4% · p75 74.5%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 09:51 UTC#ca2f8c42
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 09:53 UTCJob: fa17e8d0